Medical groups have become an attractive PE target in recent years, with investors acquiring about 1,000 such entities between 2010 and 2020, experts write in JAMA.
Researchers suggest the variables identified in their study should be considered when deciding whether to send patients for additional assessments to confirm or rule out malignancy.
"With Secretary Kennedy confirmed, there is significant work ahead to ensure patient access to imaging, address reimbursement challenges and support radiology practices nationwide,” the RBMA said.
The California company is offering a “groundbreaking” elective imaging exam that equips patients with data on brain function, cognitive health and early indicators of neurodegenerative disease.